Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2004-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.103.061002PMID 14617682
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway.

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts

  2003cited by this paper
• Differential Requirement of Gα12, Gα13, Gαq, and Gβγ for Endothelin-1-Induced c-Jun NH2-Terminal Kinase and Extracellular Signal-Regulated Kinase Activation

  2003cited by this paper
• Evidence for Cannabinoid Receptor-Dependent and -Independent Mechanisms of Action in Leukocytes

  2003cited by this paper
• Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils.

  2003cited by this paper
• Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis.

  2003cited by this paper
• Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics.

  2003cited by this paper
• Targeting the endocannabinoid system in cancer therapy: A call for further research

  2002cited by this paper
• Cannabinoid receptors and their ligands.

  2002cited by this paper
• Cannabinoids and cell fate.

  2002influential reference
• From cannabis to cannabinergics: new therapeutic opportunities.

  2002cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cited by this paper
• De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis.

  2002cited by this paper
• Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.

  2001cited by this paper
• Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation.

  2001cited by this paper
• Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

  2001cited by this paper
• Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors.

  2001cited by this paper
• Enzyme-linked immunosorbent assay (ELISA) for the specific detection of apoptotic cells and its application to rapid drug screening.

  2001cited by this paper
• Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

  2001cited by this paper
• The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

  2000cited by this paper
• Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors

  2000influential reference
• Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

  2000influential reference
• Apoptosis induced by 2‐chloro‐adenosine and 2‐chloro‐2′‐deoxy‐adenosine in a human astrocytoma cell line: Differential mechanisms and possible clinical relevance

  2000cited by this paper
• Anandamide induces apoptosis of PC‐12 cells: involvement of superoxide and caspase‐3

  2000cited by this paper
• Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway1

  2000cited by this paper
• D-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway

  2000cited by this paper
• Neuroprotective Antioxidants from Marijuana a

  2000cited by this paper
• Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability.

  2000cited by this paper
• Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

  1999cited by this paper
• Δ9‐Tetrahydrocannabinol induces apoptosis in human prostate PC‐3 cells via a receptor‐independent mechanism

  1999cited by this paper
• Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol.

  1998cited by this paper
• Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cells

  1998influential reference
• Hippocampal Neurotoxicity of Δ9-Tetrahydrocannabinol

  1998influential reference
• Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

  1998influential reference
• Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells.

  1998cited by this paper
• Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells

  1998cited by this paper
• Psychoactive Cannabinoids Increase Mortality and Alter Acute Phase Cytokine Responses in Mice Sublethally Infected with Legionella pneumophila

  1997cited by this paper
• Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

  1996cited by this paper
• Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids.

  1996cited by this paper
• Serum proteins affect the inhibition by delta-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse macrophages.

  1993cited by this paper
• The inhibition of DNA synthesis by cannabinoids.

  1976cited by this paper
• Antineoplastic activity of cannabinoids.

  1975cited by this paper

• Cannabidiol-induced cellular and matrix-associated responses in primary equine sarcoid cells.

  2026cites this paper
• Cannabinoids and the autophagy-related signaling in brain Tumors: From mechanistic insights to therapeutic Frontiers in glioblastoma.

  2026cites this paper
• Repeated administration of cannabidiol decreases splenic lymphocyte subset numbers in rats

  2026cites this paper
• Repeated administration of cannabidiol decreases splenic lymphocyte numbers in rats: involvement of CB2 receptors

  2025cites this paper
• Cannabidiol (CBD) as a novel inhibitor of HLA-G expression in human choriocarcinoma cell line (JEG-3)

  2025cites this paper
• Research mapping of cannabinoids and endocannabinoid system in cancer over the past three decades: insights from bibliometric analysis

  2025cites this paper
• From Screening to a Nanotechnological Platform: Cannabidiol–Chemotherapy Co-Loaded Lipid Nanocapsules for Glioblastoma Multiforme Treatment

  2025cites this paper
• Negative regulation of cannabinoid receptor 2‑induced tumorigenic effect by sphingosine‑1‑phosphate receptor 5 activation.

  2025cites this paper
• Cannabidiol in Gliomas: Therapeutic Potential and Nanocarrier Strategies, with an Emphasis on Vesicular Delivery Systems

  2025cites this paper
• Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer

  2025cites this paper
• Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy

  2025cites this paper
• Mechanisms of Cell Death Induced by Cannabidiol Against Tumor Cells: A Review of Preclinical Studies

  2025cites this paper
• Impact of Cannabis Leaf (Sakon Nakhon Cultivar) Extracts on Anti-Cholangiocarcinoma Activity

  2025cites this paper
• Exploring the therapeutic potential of cannabinoids in cancer by modulating signaling pathways and addressing clinical challenges

  2024cites this paper
• Eukaryotic Initiation Translation Factor 2A activation by cannabidiolic acid alters the protein homeostasis balance in glioblastoma cells.

  2024cites this paper
• Cannabidiol and fluorinated derivative anti-cancer properties against glioblastoma multiforme cell lines, and synergy with imidazotetrazine agents

  2024cites this paper
• A comprehensive update on cannabidiol, its formulations and drug delivery systems

  2024cites this paper
• Cannabidiol Enhances Atezolizumab Efficacy by Upregulating PD-L1 Expression via the cGAS–STING Pathway in Triple-Negative Breast Cancer Cells

  2024cites this paper
• The molecular anti-metastatic potential of CBD and THC from Lebanese Cannabis via apoptosis induction and alterations in autophagy

  2024cites this paper
• Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects.

  2024cites this paper
• Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines

  2024cites this paper
• The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex® - A Cannabis-derived Spray.

  2024cites this paper
• Anti-proliferative and apoptotic effect of cannabinoids on human pancreatic ductal adenocarcinoma xenograft in BALB/c nude mice model

  2024cites this paper
• Entry of cannabidiol into the fetal, postnatal and adult rat brain

  2024cites this paper
• In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities

  2024cites this paper
• Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy

  2024cites this paper
• Cannabidiol oil's effects on blood measurements in rats with experimentally generated leukemia.

  2024cites this paper
• Therapeutic targeting of the tumor microenvironments with cannabinoids and their analogs: Update on clinical trials.

  2023cites this paper
• Single-cell analyses reveal cannabidiol rewires tumor microenvironment via inhibiting alternative activation of macrophage and synergizes with anti-PD-1 in colon cancer

  2023cites this paper
• CBD as a Physiological Modulator for Cancer

  2023cites this paper
• Phytoradiotherapy to enhance cancer treatment outcomes with cannabidiol, bitter melon juice, and plant hemoglobin

  2023cites this paper
• A dual receptor targeting and blood–brain barrier penetrating co-drug-loaded particle mediating inhibition of oxidative phosphorylation for targeted therapy of glioblastoma

  2023cites this paper
• The Impact of ROS and NGF in the Gliomagenesis and their Emerging Implications in the Glioma Treatment.

  2023cites this paper
• The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential.

  2023cites this paper
• Cannabidiol and Aloe vera Extract to Human Cells: Bioactive Molecules as a Promising Anti-Lung Cancer Drug

  2023cites this paper
• Anti-proliferative and apoptotic effect of cannabinoids on human pancreatic ductal adenocarcinoma xenograft in BALB/c nude mice model

  2023cites this paper
• Treatment of malignant diseases with phytocannabinoids: promising observations in animal models and patients

  2023cites this paper
• Should oncologists trust cannabinoids?

  2023cites this paper
• Dual targeting agent Thiotert inhibits the progression of glioblastoma by inducing ER stress-dependent autophagy.

  2023cites this paper
• Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy

  2023cites this paper
• Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles

  2023cites this paper
• Could cannabinoids provide a new hope for ovarian cancer patients?

  2023cites this paper
• Discovery of Novel Small Molecule CB2 Agonist for the Treatment of Glioblastoma Tumors

  2023cites this paper
• Comparative Study of Δ9-Tetrahydrocannabinol and Cannabidiol on Melanogenesis in Human Epidermal Melanocytes from Different Pigmentation Phototypes: A Pilot Study

  2022cites this paper
• Cannabis with breast cancer treatment: propitious or pernicious?

  2022cites this paper
• Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma.

  2022cites this paper
• ROS-Induced Cancers

  2022cites this paper
• Use of Cannabis sativa derivatives for the treatment of lymphomas: what is known so far?

  2022cites this paper
• Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

  2022cites this paper
• The regulatory landscape of retinoblastoma: a pathway analysis perspective

  2022cites this paper
• Interaction of Glia Cells with Glioblastoma and Melanoma Cells under the Influence of Phytocannabinoids

  2022cites this paper
• Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations

  2022cites this paper
• Cannabidiol (CBD) in Cancer Management

  2022cites this paper
• A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)

  2022cites this paper
• Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics

  2022cites this paper
• Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles

  2022cites this paper
• Biological Effects of Cannabidiol on Human Cancer Cells: Systematic Review of the Literature.

  2022cites this paper
• A Review on Medicinal Plants Having Anticancer Properties of Northeast India and Associated Endophytic Microbes and their Future in Medicinal Science

  2022cites this paper
• Hemp in Animal Diets—Cannabidiol

  2022cites this paper
• Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges

  2022cites this paper
• Comparative changes in breast cancer cell proliferation and signalling following somatostatin and cannabidiol treatment.

  2022cites this paper
• Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies

  2021cites this paper
• Microbial Biotransformation of Cannabidiol (CBD) from Cannabis sativa

  2021cites this paper
• Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action

  2021cites this paper
• Daily Lifestyle Modifications to Improve Quality of Life and Survival in Glioblastoma: A Review

  2021cites this paper
• Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?

  2021cites this paper
• Cannabinoids and Breast Cancer

  2021cites this paper
• Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches

  2021cites this paper
• Genotoxicity of Marijuana in Mono-Users

  2021cites this paper
• CBD activation of TRPV1 induces oxidative signaling and subsequent ER stress in breast cancer cell lines

  2021cites this paper
• Cannabinoid Cancer Biology and Prevention.

  2021cites this paper
• Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence

  2021cites this paper
• Cannabidiol induces autophagy via ERK1/2 activation in neural cells

  2021cites this paper
• Efficacy of cannabinoids against glioblastoma multiforme: A systematic review.

  2021cites this paper
• Phytoradiotherapy: An Integrative Approach to Cancer Treatment by Combining Radiotherapy With Phytomedicines

  2021cites this paper
• Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?

  2021cites this paper
• Cannabinoids in the landscape of cancer

  2021cites this paper
• Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells.

  2021cites this paper
• Effects of cannabidiol (CBD) on the inhibition of melanoma cells in vitro

  2021cites this paper
• The pro-apoptosis effects of Echinacea purpurea and Cannabis sativa extracts in human lung cancer cells through caspase-dependent pathway

  2021cites this paper
• Efficacy of cannabinoids against glioblastoma multiforme : A systematic 3 review 4

  2021cites this paper
• Cannabidiol safety

  2021cites this paper
• The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects.

  2021cites this paper
• Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.

  2021cites this paper
• Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors

  2021cites this paper
• Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives

  2021cites this paper
• Reactive Species and ER-Mitochondrial Performance for Glioblastoma Multiforme Treatment Strategy

  2021cites this paper
• Cannabis and its Constituents for Cancer: History, Biogenesis, Chemistry and Pharmacological Activities.

  2020cites this paper
• Cannabinoids as anticancer therapeutic agents

  2020cites this paper
• Cannabidiol bei Tumorerkrankungen

  2020cites this paper
• Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies

  2020cites this paper
• Pharmacology of Endocannabinoids and Their Receptors

  2020cites this paper
• Developing Raman microspectroscopy as a technique to analyse single Caco-2 cell

  2020cites this paper
• The role of cannabinoids in the treatment of cancer.

  2020cites this paper
• Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition.

  2020cites this paper
• Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer

  2020cites this paper
• ReviewCannabidiol (CBD) as a Promising Anti-Cancer DrugEmily S. Seltzer 1

  2020cites this paper
• Cannabidiol (CBD) as a Promising Anti-Cancer Drug

  2020cites this paper
• Id1 and Id3 Are Regulated Through Matrix‐Assisted Autocrine BMP Signaling and Represent Therapeutic Targets in Melanoma

  2020cites this paper
• The pharmacological basis for application of cannabidiol in cancer chemotherapy

  2020cites this paper